Wasim Malik
Investing Profile
Iaso Ventures thesis
Steve Schachter, MD Dr. Steven Schachter is Chief Academic Officer for CIMIT in Boston and a Professor of Neurology at Harvard Medical School . He is Past President of the American Epilepsy Society and has served on the Epilepsy Foundation of America Board of Directors and as Chair of its Professional Advisory Board. Dr. Schachter has published over 250 articles and chapters and edited or written 40 books, including the Brainstorm Series. He is the founding editor and past editor-in-chief of the medical journals Epilepsy & Behavior and Epilepsy & Behavior Case Reports. He has extensive experie
Sector and stage focus
- Seed: Pharmaceuticals, BioTech, AI, DeepTech, Therapeutics, Health IT, Digital Health, Impact
- Series A: BioTech, Pharmaceuticals, Health IT, AI, DeepTech, Therapeutics, Digital Health, Impact
- general: Diverse Investors, Investors who were founders, Boston / New England
- Pre-seed: Pharmaceuticals, DeepTech, Health IT, AI, Digital Health, BioTech, Therapeutics, Impact
Recent investments by Wasim Malik
Wasim Malik has 6 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| ClexBio | Seed+ | Nov 2022 | $1M |
| Catena Biosciences | Seed | Mar 2023 | $5M |
| Scaffold Therapeutics | PreSeed | Mar 2022 | $1.4M |
| Deep6 AI | Series B | Jun 2022 | $30M |
| Neurona Therapeutics | Series E | Jul 2024 | $120M |
| Ryght | Seed | Aug 2023 | $4.3M |
Frequent co-investors
Wasim Malik has co-invested with: Alexsis de Raadt St. James.
Is Wasim Malik a fit for your round?
Upload your pitch deck and see whether Wasim Malik appears in your top 20 matches.
Find investors for your deck